Mark Kozloff to Safety
This is a "connection" page, showing publications Mark Kozloff has written about Safety.
Connection Strength
0.084
-
Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer. J Thorac Oncol. 2010 Mar; 5(3):354-60.
Score: 0.084
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.